These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31115142)

  • 1. Inadvertently high dialysate magnesium causing weakness and nausea in hemodialysis patients.
    Chakurkar VV; Gade PS; Godbole AV; Wadia FF; Lobo VA
    Hemodial Int; 2019 Oct; 23(4):E106-E110. PubMed ID: 31115142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of magnesium in the risk of intradialytic hypotension among maintenance hemodialysis patients.
    Geng X; Yu J; Xu J; Jin S; Shao W; Wang Y; Guo M; Cao X; Zou J; Xu X; Ding X
    Hemodial Int; 2020 Jul; 24(3):351-358. PubMed ID: 32395903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial.
    Bressendorff I; Hansen D; Pasch A; Holt SG; Schou M; Brandi L; Smith ER
    Nephrol Dial Transplant; 2021 Mar; 36(4):713-721. PubMed ID: 31764984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Observation of Serum Total Magnesium Level in Patients Undergoing Hemodialysis.
    Yang W; Wang E; Chen W; Chen C; Chen S
    Blood Purif; 2021; 50(2):196-204. PubMed ID: 32866952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypermagnesemia in hemodialysis due to excessive concentration of the element in the dialysate].
    Switlik I; Dziewanowski K
    Wiad Lek; 1990 Mar 1-15; 43(5-6):227-31. PubMed ID: 2195778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total serum and intraerythrocyte magnesium concentrations in hemodialysis patients using different dialysate solutions.
    Kusic J; Markovic R; Andjelkovic Apostolovic M; Dragovic G
    Magnes Res; 2020 May; 33(2):28-36. PubMed ID: 32900678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial.
    Tzanakis IP; Papadaki AN; Wei M; Kagia S; Spadidakis VV; Kallivretakis NE; Oreopoulos DG
    Int Urol Nephrol; 2008; 40(1):193-201. PubMed ID: 18193489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of different dialysate magnesium concentrations on QTc dispersion in hemodialysis patients.
    Afshinnia F; Doshi H; Rao PS
    Ren Fail; 2012; 34(4):408-12. PubMed ID: 22299661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease.
    Wyskida K; Witkowicz J; Chudek J; Więcek A
    J Ren Nutr; 2012 Jan; 22(1):19-26. PubMed ID: 21620724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mass transfer of magnesium in hemodialysis].
    Calzavara P; Da Porto A; Vianello A; Gatti PL; Maresca MC; Caenaro G
    Minerva Urol Nefrol; 1990; 42(4):239-41. PubMed ID: 2095641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase.
    Del Giorno R; Lavorato Hadjeres S; Stefanelli K; Allegra G; Zapparoli C; Predrag L; Berwert L; Gabutti L
    Adv Ther; 2020 Dec; 37(12):4848-4865. PubMed ID: 32996010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis Decreases the Concentration of Accumulated Plant Phenols in the Plasma of Patients on Maintenance Dialysis: Influence of Residual Renal Function.
    Nowak PJ; Wilk R; Prymont-Przyminska A; Zwolinska A; Sarniak A; Wlodarczyk A; de Graft-Johnson J; Mamelka B; Zasowska-Nowak A; Bartnicki P; Nowak D; Nowicki M
    Ther Apher Dial; 2017 Dec; 21(6):572-585. PubMed ID: 29024501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysate magnesium level and blood pressure.
    Kyriazis J; Kalogeropoulou K; Bilirakis L; Smirnioudis N; Pikounis V; Stamatiadis D; Liolia E
    Kidney Int; 2004 Sep; 66(3):1221-31. PubMed ID: 15327421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short, thrice-weekly hemodialysis is inadequate regardless of small molecule clearance.
    Twardowski ZJ
    Int J Artif Organs; 2004 Jun; 27(6):452-66. PubMed ID: 15291076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis water as a determinant of the adequacy of dialysis.
    Ward RA
    Semin Nephrol; 2005 Mar; 25(2):102-11. PubMed ID: 15791562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
    Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
    ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis.
    Guillot AP; Hood VL; Runge CF; Gennari FJ
    Nephron; 1982; 30(2):114-7. PubMed ID: 7099318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk.
    Pun PH; Middleton JP
    J Am Soc Nephrol; 2017 Dec; 28(12):3441-3451. PubMed ID: 28993507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.